| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/12/2005 | CN1562366A SARS nucleic acid vaccine and preparation method, application of S gene in coronavirus |
| 01/12/2005 | CN1562365A SARS vaccine of adenovirus carrier and preparation method, application of coronavirus S gene |
| 01/12/2005 | CN1562362A Mosaic type DNA vaccine in use for preventing tuberculosis and immunological therapy |
| 01/12/2005 | CN1562354A Method for controlling mammal to give birth of female mammal based on H-Y antigen |
| 01/12/2005 | CN1184321C Adenovirus-mediated gene therapy |
| 01/12/2005 | CN1184320C Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/12/2005 | CN1184310C Combined deletion 19 Kda, 55KDA, E1B code sequence recombination adenovirus construction body and its use |
| 01/12/2005 | CN1183968C Improved vacines |
| 01/12/2005 | CN1183959C Tumor suppressing polypeptide TSF and gene therapy vector composition |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841541 Increasing the sensitivity of a tumor cell to a chemotherapeutic agent, comprising exposing said tumor cell to anticode oligomer |
| 01/11/2005 | US6841540 Immunomodulation by genetic modification of dendritic cells and B cells |
| 01/11/2005 | US6841539 Oligonucleotide admixed with a topical penetration enhancer, isopropyl myristate |
| 01/11/2005 | US6841538 Combination therapy using nucleic acids and radio therapy |
| 01/11/2005 | US6841537 Combination therapy using nucleic acids and conventional drugs |
| 01/11/2005 | US6841381 Immunization by inoculation of DNA transcription unit |
| 01/11/2005 | US6841371 Comprises anticoagulant polypeptide for treatment and prevention of acute coronary syndromes, vascular occlusive disorders and thrombosis |
| 01/11/2005 | US6841362 Melanoma differentiation associated gene-7 promoter and uses thereof |
| 01/11/2005 | US6841158 Chicken embryo lethal orphan or fowl adenovirus type 1 genome contains a deletion consisting essentially of nucleotides 41,731-43,684 of the wild type |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/11/2005 | CA2033175C Self-assembled, defective, non-self-propagating viral particles |
| 01/06/2005 | WO2005001142A2 Methods and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 01/06/2005 | WO2005001110A2 Transcriptional regulation of gene expression by small double-stranded modulatory rna |
| 01/06/2005 | WO2005001103A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | WO2005001092A2 Compositions and methods for diagnosing and treating cancers |
| 01/06/2005 | WO2005001090A1 Method and composition for improving efficiency of transferring nucleic acid into cell |
| 01/06/2005 | WO2005001062A2 Modified vectors for organelle transfection |
| 01/06/2005 | WO2005001055A2 Stabilized immunomodulatory oligonucleotides |
| 01/06/2005 | WO2005001043A2 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi |
| 01/06/2005 | WO2005001042A2 Smooth muscle progenitor cells |
| 01/06/2005 | WO2005001030A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 01/06/2005 | WO2005001023A2 Method and carrier complexes for delivering molecules to cells |
| 01/06/2005 | WO2005000890A1 Method for transplanting lymphohematopoietic cells into mammal |
| 01/06/2005 | WO2005000889A1 Immunogenic peptides for the treatment of prostate and breast cancer |
| 01/06/2005 | WO2005000888A2 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 01/06/2005 | WO2005000355A1 Treatment of tumor by cotransferring chemotherapeutic agent with cytokine gene |
| 01/06/2005 | WO2005000336A2 The use of caldag-gefi inhibitors as antithrombotic agents |
| 01/06/2005 | WO2005000335A2 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 01/06/2005 | WO2005000318A2 Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| 01/06/2005 | WO2005000272A1 Long-circulating liposomal compositions |
| 01/06/2005 | WO2005000271A1 Method for improving stability and shelf-life of liposome complexes |
| 01/06/2005 | WO2005000235A2 NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IgE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME |
| 01/06/2005 | WO2005000220A2 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 01/06/2005 | WO2005000215A2 Methods for treating pain |
| 01/06/2005 | WO2004097025A3 A method of transducing neural stem cells bound to a fibronectin fragment |
| 01/06/2005 | WO2004096257A3 Genetic modification of targeted regions of the cardiac conduction system |
| 01/06/2005 | WO2004089417A9 Drug-enclosing multilayer structure particulate and process for producing the same |
| 01/06/2005 | WO2004082574A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 01/06/2005 | WO2004078216A3 Use of a tricyclic antidepressant drug for promoting endocytosis |
| 01/06/2005 | WO2004071378A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 01/06/2005 | WO2004054512A3 Therapeutic retroviral vectors for gene therapy |
| 01/06/2005 | WO2003050255A3 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 01/06/2005 | WO2002074234A3 Method and composition for treatment of skeletal dysplasias |
| 01/06/2005 | WO2002055700A8 Human genes and gene expression products isolated from human prostate |
| 01/06/2005 | US20050005318 Using micromanipulation and microtubule inhibitors to enucleate oocytes; generating cloned animal embryos for use in treatment and prevention nervous sytem disorders and heart disease; in vitro fertilization |
| 01/06/2005 | US20050005316 Extracellular matrix signaling molecules |
| 01/06/2005 | US20050005312 Propagation of human hepatocytes in non-human animals |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004065 Hypoxia regulated genes |
| 01/06/2005 | US20050004063 nucleotide sequence which was designed based on portions of the genomic sequences of the different strains of the hSARS virus and their use as therapeutic agents in therapeutic methods |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004060 Plasmid mediated GHRH supplementation for renal failures |
| 01/06/2005 | US20050004059 Gene amplification and overexpression in cancer |
| 01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004017 Antiproliferative agents; anticarcinogenic agents |
| 01/06/2005 | US20050004008 Determining metastatic of cancer using concentration of phosphorylated adaptor protein; anticancer agenst |
| 01/06/2005 | US20050003547 Compositions and methods for tissue specific targeting of lentivirus vectors |
| 01/06/2005 | US20050003546 Viral uptake into cells and tissues |
| 01/06/2005 | US20050003537 Composition and method for production of transformed cells |
| 01/06/2005 | US20050003534 Human stem cell materials and methods |
| 01/06/2005 | US20050003531 Isolating and generating postmitotic neurons from embryonic spinal cord tissue that are capable of multiple neuronal phenotypes for use in treatment and prevention of nervous system disorders |
| 01/06/2005 | US20050003510 Transgenic lactobacillus which has been modified to express heterologous gene products on cell wall surface for use as therapeutic tool in prevention of bacterial infection and inflammatory response |
| 01/06/2005 | US20050003505 delivering genes; gag genes, gag protein; endothelial growth factor |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003491 Secreted proteins and polynucleotides encoding them |
| 01/06/2005 | US20050003490 Immunoglobulins specific for cell surface protein for use in diagnosis, prevention and treatment of cell proliferative disorders; inhibitory action associated with reduced cellular transport of amino acids |
| 01/06/2005 | US20050003463 Method and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003439 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 01/06/2005 | US20050003437 Human oncogene induced secreted protein I |
| 01/06/2005 | US20050003433 Recombinant neospora antigens and their uses |
| 01/06/2005 | US20050003427 Dendritic enriched secreted lymphocyte activation molecule |
| 01/06/2005 | US20050003412 Protein activator of superoxide production for use in treatment and prevention of cancer, psoriasis, prostatic hypertrophy, benign prostatic hypertrophy and cardiovascular disease |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003378 Inhibitor of demethylase, antitumorigenic agent, and an in vitro assay for demethylase inhibitors |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003368 Cancer monitoring and therapeutics |
| 01/06/2005 | US20050003344 Adeno-associated viral deletion rep protein comprising functional nuclear localization sequence for use delivery of gene products to preferential intracellular locations |
| 01/06/2005 | US20050002999 Comprising phosphatidyl glycerol and phosphatidyl choline components; in vivo stable anticancer and antiinflammatory drug delivery |
| 01/06/2005 | US20050002998 Method for improving stability and shelf-life of liposome complexes |
| 01/06/2005 | US20050002986 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 01/06/2005 | US20050002982 Hybrid tissues for tissue engineering |
| 01/06/2005 | US20050002967 Kit comprised of at least three different immunogenic compositions |
| 01/06/2005 | US20050002965 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |